Editorial Comment to "Tertiary Lymphoid Structures Correlate With Better Prognosis in Patients With Retroperitoneal Sarcoma: A Retrospective Study".
作者信息
Yamamoto Yoshiyuki, Nonomura Norio
机构信息
Department of Urology, The University of Osaka Graduate School of Medicine, Suita City, Osaka Prefecture, Japan.
出版信息
Int J Urol. 2025 Jul;32(7):868-869. doi: 10.1111/iju.70092. Epub 2025 May 1.
Abstract
摘要
相似文献
1
Editorial Comment to "Tertiary Lymphoid Structures Correlate With Better Prognosis in Patients With Retroperitoneal Sarcoma: A Retrospective Study".对“三级淋巴结构与腹膜后肉瘤患者更好的预后相关：一项回顾性研究”的编辑评论
Int J Urol. 2025 Jul;32(7):868-869. doi: 10.1111/iju.70092. Epub 2025 May 1.
2
Tertiary Lymphoid Structures Correlate With Better Prognosis in Patients With Retroperitoneal Sarcoma: A Retrospective Study.三级淋巴结构与腹膜后肉瘤患者的较好预后相关：一项回顾性研究
Int J Urol. 2025 Jul;32(7):859-867. doi: 10.1111/iju.70069. Epub 2025 Apr 11.
3
Radiotherapy and surgery-an indispensable duo in the treatment of retroperitoneal sarcoma.放疗与手术——腹膜后肉瘤治疗中不可或缺的一对搭档。
Cancer. 2011 Oct 1;117(19):4355-64. doi: 10.1002/cncr.26071. Epub 2011 Mar 28.
4
A systematic review of the role of chemotherapy in retroperitoneal sarcoma by the Australia and New Zealand sarcoma association clinical practice guidelines working party.澳大利亚和新西兰肉瘤协会临床实践指南工作组对腹膜后肉瘤化疗作用的系统评价。
Cancer Treat Rev. 2024 Jan;122:102663. doi: 10.1016/j.ctrv.2023.102663. Epub 2023 Nov 25.
5
Molecular feature-based classification of retroperitoneal liposarcoma: a prospective cohort study.基于分子特征的腹膜后脂肪肉瘤分类：一项前瞻性队列研究。
Elife. 2025 May 23;14:RP100887. doi: 10.7554/eLife.100887.
6
Textbook Outcomes for Retroperitoneal Sarcoma Resection: A Multi-Centre Review.腹膜后肉瘤切除术的教科书式结局：一项多中心综述
Curr Oncol. 2025 Jun 19;32(6):364. doi: 10.3390/curroncol32060364.
7
Perioperative Systemic Therapy in Rare, Chemosensitive Subtypes of Retroperitoneal Sarcoma: A Hospital-Based Propensity Score-Matched Analysis.罕见的化疗敏感型腹膜后肉瘤围手术期全身治疗：一项基于医院的倾向评分匹配分析
Cancers (Basel). 2025 Jun 10;17(12):1931. doi: 10.3390/cancers17121931.
8
Can a Liquid Biopsy Detect Circulating Tumor DNA With Low-passage Whole-genome Sequencing in Patients With a Sarcoma? A Pilot Evaluation.液体活检能否通过低深度全基因组测序检测肉瘤患者的循环肿瘤DNA？一项初步评估。
Clin Orthop Relat Res. 2025 Jan 1;483(1):39-48. doi: 10.1097/CORR.0000000000003161. Epub 2024 Jun 21.
9
Transfer learning radiomic model predicts intratumoral tertiary lymphoid structures in hepatocellular carcinoma: a multicenter study.迁移学习放射组学模型预测肝细胞癌瘤内三级淋巴结构：一项多中心研究
J Immunother Cancer. 2025 Mar 4;13(3):e011126. doi: 10.1136/jitc-2024-011126.
10
Can We Accurately Predict Adult Height in Pediatric Patients Who Undergo Treatment for Sarcoma?我们能否准确预测接受肉瘤治疗的儿科患者的成人身高？
Clin Orthop Relat Res. 2025 Feb 6;483(7):1338-46. doi: 10.1097/CORR.0000000000003409.
本文引用的文献
1
Tertiary Lymphoid Structures Correlate With Better Prognosis in Patients With Retroperitoneal Sarcoma: A Retrospective Study.三级淋巴结构与腹膜后肉瘤患者的较好预后相关：一项回顾性研究
Int J Urol. 2025 Jul;32(7):859-867. doi: 10.1111/iju.70069. Epub 2025 Apr 11.
2
Pembrolizumab in soft-tissue sarcomas with tertiary lymphoid structures: a phase 2 PEMBROSARC trial cohort.伴三级淋巴结构的软组织肉瘤中的帕博利珠单抗：PEMBROSARC 试验队列的 2 期研究
Nat Med. 2022 Jun;28(6):1199-1206. doi: 10.1038/s41591-022-01821-3. Epub 2022 May 26.
3
B cells are associated with survival and immunotherapy response in sarcoma.B 细胞与肉瘤的生存和免疫治疗反应有关。
Nature. 2020 Jan;577(7791):556-560. doi: 10.1038/s41586-019-1906-8. Epub 2020 Jan 15.
4
Correlative Analyses of the SARC028 Trial Reveal an Association Between Sarcoma-Associated Immune Infiltrate and Response to Pembrolizumab.SARC028 试验的相关性分析显示肉瘤相关免疫浸润与帕博利珠单抗应答之间存在关联。
Clin Cancer Res. 2020 Mar 15;26(6):1258-1266. doi: 10.1158/1078-0432.CCR-19-1824. Epub 2020 Jan 3.
5
Pharmacotherapy for liposarcoma: current state of the art and emerging systemic treatments.脂肪肉瘤的药物治疗：当前的最新进展和新兴的系统治疗方法。
Expert Opin Pharmacother. 2019 Aug;20(12):1503-1515. doi: 10.1080/14656566.2019.1618271. Epub 2019 May 28.
Zotero 插件